Hikal Limited Stock price

Equities

HIKAL

INE475B01022

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:51 2024-03-28 am EDT 5-day change 1st Jan Change
264.8 INR -0.21% Intraday chart for Hikal Limited -5.80% -12.75%
Sales 2024 * 18.08B 217M Sales 2025 * 20.78B 249M Capitalization 32.65B 392M
Net income 2024 * 682M 8.19M Net income 2025 * 1.03B 12.38M EV / Sales 2024 * 1.81 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.57 x
P/E ratio 2024 *
48.1 x
P/E ratio 2025 *
31.5 x
Employees -
Yield 2024 *
0.23%
Yield 2025 *
0.23%
Free-Float 30.93%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.21%
1 week-5.80%
Current month-5.55%
1 month-5.48%
3 months-14.12%
6 months-9.78%
Current year-12.75%
More quotes
1 week
262.75
Extreme 262.75
279.00
1 month
260.65
Extreme 260.65
286.05
Current year
260.65
Extreme 260.65
312.80
1 year
258.60
Extreme 258.6
328.60
3 years
142.85
Extreme 142.85
742.00
5 years
57.00
Extreme 57
742.00
10 years
56.96
Extreme 56.96
742.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 95-12-31
Founder 76 88-07-07
Director of Finance/CFO - -
Members of the board TitleAgeSince
Founder 76 88-07-07
Chief Executive Officer 50 95-12-31
Director/Board Member 80 99-05-28
More insiders
Date Price Change Volume
24-03-28 264.8 -0.21% 35,287
24-03-27 265.4 -1.58% 31,866
24-03-26 269.6 -2.71% 31,078
24-03-22 277.1 -1.42% 11,312
24-03-21 281.1 +2.65% 15,988

Delayed Quote Bombay S.E., March 28, 2024 at 06:00 am EDT

More quotes
Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-viral, anti-inflammatory, analgesic and anti-parasitic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone and NSAID. Its crop protection product categories include algaecide, biocide, fungicide, herbicide, insecticide and intermediate.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
264.8 INR
Average target price
330 INR
Spread / Average Target
+24.62%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Hikal Limited - Bombay S.E.